anti- DR4 antibody

Unravel the mysteries of programmed cell death and apoptosis with our meticulously crafted Anti-DR4 Antibody, now available in a 100µg size. Death receptor 4 (DR4), also known as TRAIL receptor 1 (TNFRSF10A), is a central figure in the extrinsic apoptotic pathway and an attractive target for cancer and immunology research.

This highly specific antibody allows you to delve into the complexities of apoptosis with confidence. It has undergone rigorous quality control to ensure accuracy and reproducibility in your experiments, making it the perfect choice for researchers studying cancer, immunotherapy, and the mechanisms of programmed cell death.

DR4 is a cell surface receptor that plays a pivotal role in apoptosis and is a potential target for cancer therapy. Whether you're researching cancer biology, immunotherapy, or the mechanisms of apoptosis, this antibody will be your trusted companion.

Order your 100µg vial today and embark on a journey into the intricate world of apoptosis research with the precision and reliability of our Anti-DR4 Antibody. Illuminate your path in the exploration of programmed cell death and its therapeutic implications.

Product Name

DR4 antibody

Size

100µg

Form

liquid

Purification

Immunogen affinity purified

Purity

≥95% as determined by SDS-PAGE

Host

Rabbit

Clonality

polyclonal

Isotype

IgG

Storage

PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)

IMMUNOGEN INFORMATION

Immunogen

tumor necrosis factor receptor superfamily, member 10a

Synonyms

APO2, CD261, Death receptor 4, DR4, TNFRSF10A, TRAIL R1, TRAIL receptor 1, TRAILR 1, TRAILR1

Observed MW

44-50 kDa

APPLICATION

Tested Application

ELISA, WB, IF

Recommended Dilution

WB: 1:500-1:2000; IF: 1:20-1:200

UNIPROT INFORMATION

UniProt ID

O00220

IMAGES

Rat lung tissue were subjected to SDS PAGE followed by western blot with FNab10828(DR4 antibody) at dilution of 1:1000